Even though an approved vaccine for hepatitis B virus (HBV) is available and widely used,
over 257 million individuals worldwide are living with chronic hepatitis B (CHB) who require …

Background & Aims The accurate diagnosis of occult hepatitis B virus (HBV) infection (OBI)
requires the demonstration of HBV DNA in liver biopsies of hepatitis B surface antigen …

Currently, there are several drugs approved for the treatment of chronic hepatitis B including
recombinant interferons, such as Interferon-α and its pegylated formulation, and the nucleos …

Abstract Introduction Hepatitis D Virus (HDV) infection is vanishing in Italy. It is therefore
believed that hepatitis D is no longer a medical problem in the domestic population of the …

Objectives We assessed the analytical and clinical performance of the Lumipulse® G HBcAb-
N (Fujirebio, Japan) assay for IgG antibodies to hepatitis B core antigen (anti-HBc IgG) …

Data on the prevalence of occult HBV infection (OBI) in Western Europe and in Northern
America are few; hence, we conducted a systematic review and meta‐analysis. All studies …

Aim The aim of this study was to evaluate the correlation between hepatitis B core‐related
antigen (HBcrAg) and hepatitis B virus (HBV) DNA and hepatitis B surface antigen (HBsAg) …

In patients with chronic hepatitis B (CHB) under long-term treatment with nucleso (t) ide
analogues (NAs), the loss of hepatitis B surface antigen (HBsAg) is a rare event. A growing …

Due to a lack of standardized tests, it is difficult to obtain prevalence data and define the real
impact of occult HBV infection (OBI) in Western countries. The present review article …

Even though an approved vaccine for hepatitis B virus (HBV) is available and widely used,
over 257 million individuals worldwide are living with chronic hepatitis B (CHB) who require …